02780nam 2200613 a 450 991079697760332120180314104846.01-4963-8914-X(CKB)4100000005043488(MiAaPQ)EBC5944616(DLC) 2018012516(DLC)9781496389138(EXLCZ)99410000000504348820180313d2018 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierHandbook of targeted cancer therapy and immunotherapy[electronic resource] /editors, Daniel D. Karp, Gerald S. Falchook2nd ed.Philadelphia Wolters Kluwer[2018]1 online resource (319 pages)Includes index.1-4963-8913-1 Includes bibliographical references and index."The exponential growth of oncology drug development and personalized/targeted therapy in the recent years has presented a challenge to even the most experienced cancer researchers. Many of us struggle to keep up with the hundreds of clinical trials conducted each year. To help with this challenge, we present here the second edition of our concise handbook intended to make the results of clinical trials of targeted cancer treatments and immunotherapy more easily accessible to cancer researchers and clinicians. We are very proud of the reception the first edition received from oncologists, medical staff, students, and even patients, and we are excited about the updated and widely expanded content included in this second edition"--Provided by publisher.Targeted cancer therapy and immunotherapyNeoplasmsdrug therapyMolecular Targeted TherapymethodsAntineoplastic Agentsadministration & dosageAntineoplastic AgentsmetabolismAntineoplastic Agents, ImmunologicalCancerChemotherapyDrug targetingCancerTreatmentHandbooksNeoplasmsdrug therapyMolecular Targeted TherapymethodsAntineoplastic Agentsadministration & dosageAntineoplastic AgentsmetabolismAntineoplastic Agents, ImmunologicalCancerChemotherapy.Drug targeting.CancerTreatment.616.99/4061Karp Daniel D1546286Falchook Gerald S1546287DNLM/DLCDLCBOOK9910796977603321Handbook of targeted cancer therapy and immunotherapy3801756UNINA